Bayer

Customer sentiment for Bayer is notably complex and often polarized. On one hand, many consumers hold a deep-seated trust in its long-established pharmaceutical and consumer health products, such as Aspirin, Aleve, and Claritin, valuing their proven efficacy and reliability. This segment views Bayer as a cornerstone of healthcare, a brand synonymous with scientific innovation and trusted remedies. However, the acquisition of Monsanto and the subsequent legal battles surrounding products like Roundup have significantly impacted the brand's overall perception. A substantial portion of the public, particularly those concerned with environmental and health issues, views Bayer with skepticism, associating it with controversial agricultural practices and corporate litigation. This dichotomy means that while individual product lines often enjoy positive reception, the overarching corporate brand faces considerable reputational challenges, leading to a mixed and often contentious public opinion.